Riferimenti
Bibliografici
1.
Altuvia Y., Landgraf P., Lithwick G., Elefant N., Pfeffer S., Aravin A., Brownstein M.J., Tuschl T. e Margalit H. Clustering andconservation patterns of human microRNAs (2005). Nucleic Acids Res. 33(8): 2697–2706
2.
Baskerville S. e Bartel .D.P. Microarray profiling of microRNAsreveals frequent coexpression with neighboring miRNAs and host genes (2005). RNA 11: 241-247
3.
Bell L. A. e Ryan K. M. Life and death decisions by E2F-1 (2004).Cell Death and Differentiation 11: 137-142
4.
Bengert P. e Dandekar T. Current efforts in the analysis of RNAitarget genes (2004). Brief. In Informatics, 6 (1): 72-85.
5.
Braig M. e Schmitt C. A. Oncogene-Induced Senescence: Puttingthe Brakes on Tumor Development (2006). Cancer Res. 66:(6)
6.
Brennecke J., Stark A., Russel R. B., Cohen S. M. Principles ofMicroRNA-Target Recognition (2005). PLoS Biol. E85.
7.
Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M. e Croce C.M. Human microRNA genes are frequently located atfragile sites and genomic regions involved in cancers (2004). PNAS
101: 2999-3004
8.
Carmell M. A., Xuan Z. Zhang M. Q., Hannon G. J. The Argonautefamily : tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis (2002). Genes & Dev.
16: 2733-2742.
9.
Chapman E. J., Prokhnevsky A. I., Gopinath K., Dolja V.V. e Carrington J.C. Viral RNA silencing suppressors inhibit themicroRNA pathway at an intermediate step (2004). Genes & Dev.
18: 1179-1186
10. Chondrogianni N., Stratford F. L. L., Trougakos I. P., Friguet B.,
Rivett A. J., Gonos E. S. Central Role of the Proteasome inSenescence and Survival of Human fibroblasts –Induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation (2003). J. Biol. Chem. 278(30):
28026-28037.
11. Dimri G. P. What has senescence got to do with cancer? (2005)
Cancer Cell, 7(6):505-512
12. Haber D.A. Splicing into Senescence: The Curious Case of p16 and
p19ARF (1997). Cell, 91: 555-558
13. He L., Hannon G. J. MicroRNAs: Small RNAs with a big role in gene
14. He L., Thomson J. M., Hemann M. T., Hernando-Monge E., Mu D.,
Goodson S., Powers S., Cordon-Carlo C., Lowe S. W., Hannon G., Hammond S. M. A microRNA polycistron as a potential humanoncogene (2005). Nature 435: 828-833.
15. Hershko T., Chaussepied M., Oren M. e Ginsberg D. Novel link
between E2F and p53: proapoptotic cofactors of p53 are trascriptionally upregulated by E2F (2005). Cell Death and Differetiation 12: 377-383.
16. Hertel J., Lindemeyer M., Missal K., Fried C., Tanzer A., Flamm C.,
Hofacker I. L., Stadler P. F. e The Students of Bioinformatics Computer Labs 2004 and 2005. The expansion of the metazoanmicroRNA repertoire (2005). BMC Genomics, 7:25
17. Holland-Frei CANCER MEDICINE 6 (2003). BC Decker Inc
18. Inoshita S., Terada Y., Nakashima O., Kuwahara M., Sasaki S. e
Marumo F. Regulation of the G1/S transition phase in mesangialcells by E2F1 (1999). Kidney International 56:1238-1241
19. Itahana K., Zou Y., Itahana Y., Martinez J.-L., Beausejour C.,
Jacobs J. J. L., van Lohuizen M., Bans V., Campisi J., Dimri G. P.Control of the Replicative Life Spen of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1 (2003). Mol. Cell. Biol. 23(1):
389-401.
20. Jacobs J. J. L., Scheijen B., Voncken J-W., Kieboom K., Berns A.,
van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis byinhibiting c-Myc-induced apoptosis via INK4A/ARF (1999). Genes & Dev. 13: 2678-2690
21. Jovanovic M. e Hengartner M. O. miRNAs and apoptosis: RNAs to
die for (2006). Oncogene, 25: 6176-6187.
22. Kamijo T., Weber J. D., Zambetti G., Zindy F., Roussel M. F., Sherr
C. J. Functional and physical interaction of the ARF tumorsuppressor with p53 and Mdm2 (1998). Proc. Natl. Acad. Sci. USA
95: 8292-8297.
23. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J.,
MacMenamin P., da Piedade I., Gunsalus K. C., Stoffel M. e Rajewsky N. Combinatorial microRNA target prediction (2005).Nat. Gen. 37(5): 495-500
24. Książek K., Piwocka K., Brzezińska A., Sikora E., Zabel M.,
Bręborowicz A., Jörres A. e Witowski J. Early loss of proliferativepotential of human peritoneal mesothelial cell in culture: the role of p16INK4A-mediated premature senescence (2006). J. Appl.
25. Kuo M.-L., Duncavage E. J., Mathew R., den Besten W., Pei D.,
Naeve D., Yamamoto T., Cheng C., Sherr C. J., Roussel M. F. ArfInduces p53-dependent and –independent Antiproliferative Genes
(2003). Cancer Res. 63: 1046-1053.
26. Laudes M., Christodoulides C., Sewter C., Rochford J. J., Considine
R. V., Sethi J. K., Vidal-Puig A., O’Rahilly S. The POZ Zinc FingerTranscriprion Factor FBI-1 in Human and Murine Adipogenesis
(2003). Biol. Chem. 279(12): 11711-11718.
27. Lee Y. S., Kim H. K., Chung S., Kim K.-S. e Dutta A. Depletion of
Human Micro-RNA miR-125b Reveals That It is Critical for the Proliferation of Differentiated Cells, but Not for the Down-regulation of Putative Targets during Differentiation (2005) J. Biol. Chem. 280(17): 16635-16641
28. Liu C., Prazak L., Fajardo M., Yu S., Tyagi N., Di Cesare P. E.
Leukemia/Lymphoma-related Factor, a POZ Domain-containing Transcriptional Repressor, Interacts with Histone Deacetilase-1 and Inhibits Cartilage Oligomeric Matrix Protein Gene Expression and Chondrogenesis (2004). J. Biol. Chem. 279(45): 47081-47091
29. Lui J., Valencia-Sanchez M. A., Hannon G. J., Parker R.
MicroRNA-dependent localisation of targeted mRNAs to mammalian P-bodies
(2005). Nat. Cell Biol. 7(7): 719-723.
30. Lodish, Berk, Zipursky, Matsudaria, Baltimore, Darnell.
MOLECULAR CELL BIOLOGY (2000). W. H. Freeman and Company
31. Luciano D. J., Mirsky H., Vendetti N. J., Maas S. RNA editing of a
miRNA precursor (2004) RNA 10: 1174-1177.
32. Maeda T., Hobbs R. M. e Pandolfi P. P. The Transcription Factor
Pokemon: A New Key Player in Cancer Pathogenesis (2005). Cancer Res. 65(19).
33. Maeda T., Hobbs R. M., Merghoub T., Guernah I., Zelent A.,
Cordon-Cardo C., Teruya-Feldstein J. e Pandolfi P. P. Role of theproto-oncogene Pokemon in cellular transformation and AFR repression (2005). Nature, 443: 278-285
34. Maehara K., Yamakoshi K., 37, Otani N., Kubo Y., Takahashi A.,
Arase S., Jones N. ed Hara E.. Reduction of total E2F/DP activityinduces senescent-like cell cycle arrest in cancer cell lacking functional pRb and p53 (2005). J. Cell Biol. 168(4): 553-560
35. Martelli F., Hamilton T., Silver D. P., Sharpless N. E., Bardeesy N.,
Rokas M., DePinho R. A., Livingston D. M., Grossman S. R. p19ARFtargets certain E2F species for degradation (2001). 98:
36. Mason D. X., Jackson T. J. e Lin A. W. Molecular signature of
oncogenic ras-induced senescence (2004). Oncogene, 23:
9238-9246.
37. Melendez B., Malumbres M., Pérez del Castro I., Santos J., Pellicer
A., Fernàndez-Piqueras J. Characterization of the murine p19ARFpromoter CpG island and its metylation pattern in primary lymphomas (2000). Carcinogenesis 4(21): 817-821
38. Mundle S. D. e Saberwal G. Evolving intricacies and implications of
E2F1 regulation (2003). FASEB J. 17: 569-574
39. Nakahara K e Carthew R. W. Expanding roles for miRNAs and
siRNAs in cell regulation (2004). Curr. Op. in Cell Biol. 16:127-133
40. Obata M., Imamura E., Yoshida Y., Goto J., Kishibe K., Yasuda A.,
Ogawa K. Resistance of Primary Cultured Mouse Hepatic TumorCells to Cellular Senescence Despite Expression of p16Ink4a, p19Arf,
p53, and p21Waf1/Cip1(2001). Mol Carcinogenes. 32: 9-18
41. Otani N., Yamakoshi K., Takahashi A. ed Hara E. The p16
INK4A -RBpathway: molecular link between cellular senescence and tumor suppression (2004). J. Med. Invest. 51: 146-153
42. Place R. F., Noonan E. J. e Giardina C. HDACs and the senescent
phenotype of WI-38 cells (2005). BMC cell biology, 6:37.
43. Quelle D. E., Cheng M., Ashmun R. A., Sherr C. J.
Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternate reading frame protein p19ARF
(1997). Proc. Natl. Acad. Sci USA 94: 669-673.
44. Randle D. H., Zindy F., Sherr C. J., Roussell M. Differential effects
of p19Arf and p16Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages (2001). Proc. Natl. Acad. Sci. USA 17(98): 9654-9659.
45. Ries S., Biederer C., Woods D., Shifman O., Shirasawa S.,
Sasazuki T., McMahon M., Oren M. e McCormick F. Opposingeffects of Ras on p53: Transcriptional Activation of mdm2 and Induction of p19ARF (2000). Cell, 103: 321-330.
46. Rodriguez A., Griffiths-Jones S., Ashurst J.L. e Bradley A.
Identification of Mammalian microRNA Host Genes and Transcription Units (2004). Genome Res. 14: 1902-1910
47. Sætrom P., Heale B.S.E., Snøve Jr O., Aagaard L., Alluin J. e Rossi
J.J. Distance constraints between microRNA target sites dictateefficacy and cooperativity (2007). Nucl. Acid Res. 35(7): 2333–
48. Sempere L. F., Sokol N. S., Dubrovsky E. B., Berger E. M. e
Ambros V. Temporal regulation of microRNA espressione inDrosophila melanogaster mediated by hormonal signals and Broad-Complex gene activity (2003). Dev. Biol. 259: 9-18
49. Sempere L. F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky
E. e Ambros V. Expression profiling of mammalian microRNAsuncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation (2004). Genome Biol. 5: R13
50. Schulman B.R.M., Esquela-Kerscher A., Slack F. J. Reciprocal
Expression of lin-41 and the MicroRNAs let-7 and mir-125 During Mouse Embryogenesis (2005). Develop. Dynamics. 234:
1046-1054.
51. Schwarz D. S., Hutvàgner G., Du T., Xu Z., Aronin N., Zamore P.D.
Asymmetry in the Assembly of the RNAi Enzyme Complex (2003) Cell, 115: 199-206.
52. Sharpless N. E., Ramsey M. R., Balasubramanian P., Castrillon D.
H., DePinho R. A. The differential impact of p16INK4A or p19ARFdeficiency on cell growth and tumorigenesis (2004). Oncogene 23:
379-385
53. Si K., Maitra U. The Saccharomyces cerevisiae Homologue of
Mammalian Translation Initiation Factor 6 Does Not Function as a Translation Initiation Factor (1999). Mol. Cell. Biol. 2(19):
1416-1426.
54. Sviderskaya E. V., Hill S. P., Evans-Whipp T J., Chin L., Orlow S. J.,
Easty D. J., Ching Cheong S., Beach D., DePinho R. A., Bennett D. C. p16Ink4a in Melanocyte Senescence and differentiation (2002). J.Nat. Cancer Instit. 94(6): 446-454
55. Takahashi A., Ohtani N., Yamakoshi K., Iida S., Tahara H.,
Nakayama K., Nakayama K. I., Ide T., Saya H. ed Hara E.Mitogenic signalling and the p16INK4A-RB pathway cooperate to
enforce irreversible cellular senescence (2006) Nat. Cell Biol.
8(11): 1291-1297
56. Volinia S, Calin G.A., Liu C.-G., Ambs S., Cimmino A., Petrocca F.,
Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C. e Croce C.M.. A microRNA expression signature of human solidtumors defines cancer gene targets (2006). PNAS 103: 2257-2261
57. Weston M. D., Pierce M. L., Rocha-Sanchez S., Beisel K. W. e
Soukup G. A. MicroRNA gene expression in the mouse inner ear (2006). Brain Res. 1111:96-10458. Wienholds E., Koudijs M. J., van Eeden F. J. M., Cuppen E.,
Plasterk R. H. A. The MicroRNA-producing enzyme Dicer1 isessential for zebrafish development (2003). Nature 35(3):
217-218.
59. Wu L., Fan J., Belasco J. G. Micro-RNAs direct rapid deadenilation
of mRNA (2006). 103(11): 4034-4039.
60. Wu L., Belasco J. G. Micro-RNA Regulation of the Mammalian lin-28
Gene during Neuronal Differentiation of Embryonal Carcinoma Cells